About
Tango Therapeutics Inc (NASDAQ:TNGX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
Mar 5 2026
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
Mar 5 2026
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Feb 18 2026
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
Feb 3 2026
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Financials
Revenue
$62.38 M
Market Cap
$3.09 B
EPS
-0.87
Google Übersetzer